Impact Brochure on Counterfeit Medicines - World Health Organization

IMPACT ContactsChairVice-ChairsDr Howard Zucker, Assistant Director-General,Health Technology and Pharmaceuticals, WHOzuckerh@who.intProf Dora N. Akunyili, Director General, National Agency for Food and DrugAdministration and Control (NAFDAC), Nigeriadnakunyili@yahoo.comMs Ruth Lee, Health Sciences Authority, Singapore, andMember of the Permanent Forum on International Pharmaceutical Crimeruth_lee@hsa.gov.sgChair of Working Group on Legislativeand Regulatory InfrastructureChair of Working Group on RegulatoryImplementationCo-Chairs of Working Groupon EnforcementDr Konstantin Keller, Federal Ministry of Health, Germanykonstantin.keller@bmg.bund.deDr Ilisa Bernstein, Director of Pharmacy Affaires, Food and Drug Administration, USAIlisa.Bernstein@fda.govMs Aline Lecadre, Interpola.lecadre@interpol.intMr Eric McIntosh, Therapeutic Goods Administration, AustraliaEric.McIntosh@health.gov.auChair of Working Group on TechnologyDr Harvey Bale, Director General, International Federation of PharmaceuticalManufacturers and Associationsh.bale@ifpma.orgChair of Working Group on Communication Mr Ton Hoek, Secretary-General, International Pharmaceutical Federation, FIPhoek@fip.orgExecutive SecretaryDr Valerio Reggi, Coordinator, Medicines Regulatory Support, Department of TechnicalCooperation for Essential Drugs and Traditional Medicine, WHOreggiv@who.intI nternational M edical P roductsA nti-C ounterfeiting T askforceSupport, additional information: www.who.int/impact